Announcements Trials

Browse Landscape

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 1 Breast Neoplasms 1

Interventions

pembrolizumab 58 Gemcitabine 37 Biopsy 33 Specimen Handling 32 Paclitaxel 30 Magnetic Resonance Spectroscopy 30 Nivolumab 29 Cisplatin 25 Irinotecan 24 Carboplatin 24 Cyclophosphamide 23 Fluorouracil 22 Bevacizumab 22 Docetaxel 21 Oxaliplatin 19 Leucovorin 18 Ipilimumab 17 Cetuximab 17 Capecitabine 17 130-nm albumin-bound paclitaxel 16 Everolimus 15 Albumin-Bound Paclitaxel 15 Trastuzumab 13 olaparib 12 Pemetrexed 12 Erlotinib Hydrochloride 12 spartalizumab 11 Sorafenib 11 Radiosurgery 11 trastuzumab deruxtecan 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Neoplasm Metastasis × Estradiol × Clear all

NCT05900895 2025-11-20

PHOEBE

Dartmouth-Hitchcock Medical Center

Phase 1 Recruiting

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡